[1]
Hernández-Hernández R,Sosa-Canache B,Velasco M,Armas-Hernández MJ,Armas-Padilla MC,Cammarata R, Angiotensin II receptor antagonists role in arterial hypertension. Journal of human hypertension. 2002 Mar [PubMed PMID: 11986904]
[2]
Maggioni AP, Efficacy of Angiotensin receptor blockers in cardiovascular disease. Cardiovascular drugs and therapy. 2006 Aug [PubMed PMID: 16915347]
[3]
Cernes R,Mashavi M,Zimlichman R, Differential clinical profile of candesartan compared to other angiotensin receptor blockers. Vascular health and risk management. 2011 [PubMed PMID: 22241949]
[4]
Maggioni AP,Latini R, The angiotensin-receptor blockers: from antihypertensives to cardiovascular all-round medications in 10 years? Blood pressure. 2002 [PubMed PMID: 12523675]
[5]
Weber MA, The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease. Reviews in cardiovascular medicine. 2002 Fall [PubMed PMID: 12556752]
[6]
Malacco E,Santonastaso M,Varì NA,Gargiulo A,Spagnuolo V,Bertocchi F,Palatini P, Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study. Clinical therapeutics. 2004 Jun [PubMed PMID: 15262456]
[7]
Rodgers JE,Patterson JH, Angiotensin II-receptor blockers: clinical relevance and therapeutic role. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2001 Apr 15 [PubMed PMID: 11329759]
[8]
Ventura M,Maraschini A,D'Aloja P,Kirchmayer U,Lega I,Davoli M,Donati S, Drug prescribing during pregnancy in a central region of Italy, 2008-2012. BMC public health. 2018 May 15 [PubMed PMID: 29764430]
[9]
Wadelius M,Marshall SE,Islander G,Nordang L,Karawajczyk M,Yue QY,Terreehorst I,Baranova EV,Hugosson S,Sköldefors K,Pirmohamed M,Maitland-van der Zee AH,Alfirevic A,Hallberg P,Palmer CN, Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system. Clinical pharmacology and therapeutics. 2014 Oct [PubMed PMID: 24960520]
[10]
Kumar S,Ram CV, Angiotensin receptor blockers: current status and future prospects. Indian heart journal. 2007 Nov-Dec [PubMed PMID: 19151457]
[11]
Balit CR,Gilmore SP,Isbister GK, Unintentional paediatric ingestions of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists. Journal of paediatrics and child health. 2007 Oct [PubMed PMID: 17854454]
[12]
Prasa D,Hoffmann-Walbeck P,Barth S,Stedtler U,Ceschi A,Färber E,Genser D,Seidel C,Deters M, Angiotensin II antagonists - an assessment of their acute toxicity. Clinical toxicology (Philadelphia, Pa.). 2013 Jun [PubMed PMID: 23692319]
[13]
Perk J,De Backer G,Gohlke H,Graham I,Reiner Z,Verschuren M,Albus C,Benlian P,Boysen G,Cifkova R,Deaton C,Ebrahim S,Fisher M,Germano G,Hobbs R,Hoes A,Karadeniz S,Mezzani A,Prescott E,Ryden L,Scherer M,Syvänne M,Scholte op Reimer WJ,Vrints C,Wood D,Zamorano JL,Zannad F, European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). European heart journal. 2012 Jul [PubMed PMID: 22555213]
[14]
Paulis L,Foulquier S,Namsolleck P,Recarti C,Steckelings UM,Unger T, Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders. Drugs. 2016 Jan [PubMed PMID: 26631237]